• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢畸胎瘤中发生的神经内分泌肿瘤的更新形态学和免疫组织化学特征:一大系列罕见且异质性疾病

Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease.

作者信息

Leclerc J, Tihy M, Genestie C, Chen R, Hentic O, Koskas M, Gouy S, Scoazec J Y, Couvelard A, Bucau Margot

机构信息

Department of Pathology, Centre Hospitalo-Universitaire de Rouen, Rouen, France.

Department of Pathology, Hôpital Bichat, AP-HP, Paris, France.

出版信息

Int J Surg Pathol. 2025 May;33(3):605-614. doi: 10.1177/10668969241271923. Epub 2024 Oct 7.

DOI:10.1177/10668969241271923
PMID:39370906
Abstract

IntroductionOvarian neuroendocrine tumors are rare and often arise within mature teratoma of the ovary. No recent re-evaluation of the immunophenotype of these tumors with the new markers available in the field of neuroendocrine neoplasms has been performed. The objectives were to describe the morphologic and immunohistochemical characteristics of neuroendocrine tumors (NETs) arising from ovarian teratomas, to correlate them with the type of teratomatous epithelial components present and to evaluate their proliferative activity using the WHO recommendations for gastroenteropancreatic NETs.Materials and MethodsThis is a bi-centric retrospective study using a panel of markers (chromogranin-A, chromogranin-B, synaptophysin, CDX2, SATB2, TTF1, PAX8, islet-1, serotonin and calcitonin) and Ki-67 proliferation index.ResultsThe 34 NETs studied were unilateral and presented when it's done four distinct immunophenotypic profiles: 8 NETs expressed serotonin and CDX2 (small intestinal profile), 12 SATB2 (colorectal profile), one TTF1 (thoracic profile) and 4 "null" tumors expressed none of the above markers. The Ki-67 index ranged from 0 to 19.82% (median: 1.51%). 28 tumors were grade 1 (85%), 5 tumors were grade 2 (15%). They were associated with squamous (n = 26), respiratory (n = 23), thyroid (n = 10) and gastrointestinal (n = 5) components.Discussion and ConclusionThe main type of NET is intestinal phenotype, but rarely accompanied with digestive tissue. This suggests that the cell of origin may be a neuroendocrine precursor present in the teratoma, and confirms that primary NETs arising in ovarian teratomas should not be classified or named according to the type of the surrounding teratoma tissue.

摘要

引言

卵巢神经内分泌肿瘤较为罕见,常发生于卵巢成熟畸胎瘤内。目前尚未对这些肿瘤的免疫表型进行重新评估,以采用神经内分泌肿瘤领域的新标志物。本研究旨在描述源于卵巢畸胎瘤的神经内分泌肿瘤(NETs)的形态学和免疫组化特征,将其与畸胎瘤上皮成分类型相关联,并根据世界卫生组织对胃肠胰神经内分泌肿瘤的推荐来评估其增殖活性。

材料与方法

这是一项双中心回顾性研究,使用了一组标志物(嗜铬粒蛋白A、嗜铬粒蛋白B、突触素、CDX2、SATB2、TTF1、PAX8、胰岛1、血清素和降钙素)以及Ki-67增殖指数。

结果

所研究的34例神经内分泌肿瘤均为单侧,呈现出四种不同的免疫表型:8例神经内分泌肿瘤表达血清素和CDX2(小肠型),12例表达SATB2(结肠型),1例表达TTF1(胸型),4例“无特征”肿瘤不表达上述任何标志物。Ki-67指数范围为0至19.82%(中位数:1.51%)。28例肿瘤为1级(85%),5例肿瘤为2级(15%)。它们与鳞状(n = 26)、呼吸(n = 23)、甲状腺(n = 10)和胃肠道(n = 5)成分相关。

讨论与结论

神经内分泌肿瘤的主要类型为肠型,但很少伴有消化组织。这表明起源细胞可能是畸胎瘤中存在的神经内分泌前体细胞,并证实卵巢畸胎瘤中发生的原发性神经内分泌肿瘤不应根据周围畸胎瘤组织的类型进行分类或命名。

相似文献

1
Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease.卵巢畸胎瘤中发生的神经内分泌肿瘤的更新形态学和免疫组织化学特征:一大系列罕见且异质性疾病
Int J Surg Pathol. 2025 May;33(3):605-614. doi: 10.1177/10668969241271923. Epub 2024 Oct 7.
2
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.依维莫司治疗胰腺外神经内分泌肿瘤的疗效与安全性:文献综述
Oncologist. 2016 Jul;21(7):875-86. doi: 10.1634/theoncologist.2015-0420. Epub 2016 Apr 6.
6
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
7
Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.子宫颈神经内分泌肿瘤:对妇科肿瘤学家的治疗挑战。
Gynecol Oncol. 2017 Mar;144(3):637-646. doi: 10.1016/j.ygyno.2016.12.003. Epub 2017 Jan 3.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.